DALLAS, March 16, 2026 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC) and Trinity Capital Inc. (Nasdaq: TRIN), two leading internally managed business development companies, today announced that they have formed a joint venture that will invest primarily in first-out senior secured debt opportunities in the lower middle market. The joint venture will be owned equally by Capital Southwest and Trinity Capital, with each firm committing $50 milli ...

Capital Southwest and Trinity Capital Announce Formation of New Joint Venture Accessibility StatementSkip Navigation--DALLAS and PHOENIX, March 16, 2026 /PRNewswire/ -- Capital Southwest Corporation(Nasdaq: CSWC) and Trinity Capital Inc.(Nasdaq: TRIN), two leading internally managed business development companies, today announced that they have formed a joint venture that will invest primarily in first-out senior secured debt opportunities in the lower middle market.The joint venture will be owned equally b ...

Company Overview - Trinity Capital operates as a Business Development Company (BDC), focusing on lending to growth-stage companies rather than investing in public equities [1] - GGT is a closed-end fund managed by Gabelli Funds, investing in media and telecommunications companies, with a fixed share count that can trade at a discount or premium [2] Financial Performance - Trinity's revenue for 2025 grew 24% year-over-year to $293.7 million, with a dividend coverage ratio of 102% [5][8] - GGT has maintained uninterrupted distributions for over 26 years, recently increasing monthly payments to $0.07 to $0.08 per share [5][2] Market Position and Stability - Both Trinity Capital and Gabelli Multimedia Trust outperformed the S&P 500 over the past month, with GGT up 0.48% and TRIN up 0.10%, while the S&P 500 fell approximately 4.3% [5][7] - The elevated VIX at 27.29 indicates increased market uncertainty, driving income-focused investors towards BDCs and closed-end funds like Trinity and GGT [4][3] Dividend and Yield - Trinity's effective yield on its debt portfolio was 15.2% in Q4 2025, with a shift to monthly dividend payments of $0.17 per share starting January 2026 [1] - GGT's return engine relies on the appreciation of its media-sector holdings and steady distributions, transitioning to monthly payments [2] Investment Considerations - Trinity's share count increased from 59.4 million to 77 million year-over-year, which diluted existing shareholders despite total earnings growth [11] - GGT's concentration in the media sector exposes it to structural headwinds, reflected in its five-year total return of -12% [12]

Group 1 - The article suggests that now is an opportune time for investors to start deploying cash positions that have been accumulated recently [1] - Austin Rogers is identified as a REIT specialist focused on high-quality dividend growth stocks, aiming to generate a safe and growing passive income stream [2] - The investing group High Yield Landlord is highlighted as one of the largest real estate investment communities on Seeking Alpha, providing exclusive research and multiple real money portfolios [2] Group 2 - The analyst has disclosed a beneficial long position in several stocks, indicating a personal investment interest in ARES, BX, BAM, CGDG, TDIV, HTGC, TRIN, and IIPR.PR.A [3] - Seeking Alpha emphasizes that past performance does not guarantee future results and that no specific investment recommendations are being made [4]

Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris Medical to Support Neurosurgical Technology Advancements Accessibility Statement Skip NavigationPHOENIX, March 12, 2026 /PRNewswire/ -- Trinity Capital Inc.(Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to Monteris Medical("Monteris"), a MedTech company specializing in minimally invasive neurosurgical technology.Monteris Medical develops ...

When people say they’re looking for “dividend stocks,” many investors default to a handful of popular companies like Coca-Cola, Abbott Labs, PepsiCo, and Realty Income as the top suggestions. And I don’t blame them; I’ve written about all these companies before, and yes, they offer very attractive yields, packaged with consistency and reliability. However, these companies are considered safe, conservative choices. More News from Barchart Some investors might want to make their money work harder. And in ...

We started covering the 7.875% Notes Due 2029 ( TRINZ ) from Trinity Capital ( TRIN ) last year, when we assigned the debentures a 'Buy' rating. A lot has happened in the BDC space since, and todayWith an investment banking cash and derivatives trading background, Binary Tree Analytics ('BTA') aims to provide transparency and analytics in respect to capital markets instruments and trades. BTA focuses on CEFs, ETFs and Special Situations, and aims to deliver high annualized returns with a low volatility prof ...

Core Insights - Emboline, Inc. has secured $20 million in growth capital from Trinity Capital to support the commercialization of its Emboliner® Embolic Protection System, aimed at minimizing stroke risk during transcatheter aortic valve replacement (TAVR) procedures [1][1][1] Company Overview - Emboline, Inc. is a privately held medical technology company based in Santa Cruz, California, focused on developing technologies to reduce embolic complications during transcatheter cardiovascular procedures [1][1] - The company's lead product, the Emboliner® Embolic Protection System, is designed to provide full cerebral and systemic embolic protection by capturing and removing debris released during structural heart interventions [1][1] Funding and Development - The funding from Trinity Capital will support Emboline's upcoming commercial launch activities and the continued development of its embolic protection technology platform [1][1] - Emboline has completed enrollment in the PROTECT H2H investigational device exemption (IDE) clinical trial, which evaluates the Emboliner® system [1][1] Clinical and Regulatory Milestones - Results from the completed IDE clinical study will be presented at the American College of Cardiology Annual Scientific Session on March 29, 2026 [1][1] - The financing positions Emboline to prepare for a commercial launch in the United States and Europe later this year [1][1] Strategic Partnerships - Trinity Capital, an international alternative asset manager, has a history of deploying over $5.5 billion across more than 463 investments since its inception in 2008, indicating a strong partnership for Emboline [1][1]

Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology Accessibility Statement Skip NavigationPHOENIX, March 11, 2026 /PRNewswire/ -- Trinity Capital Inc.(Nasdaq: TRIN) ("Trinity"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to Emboline, Inc.("Emboline"), a MedTech company focused on reducing strokes and other complications during interventional heart procedures ...

Like other private credit companies in the industry, Trinity Capital ( TRIN ) has suffered selling pressure due to concerns about the performance of SaaS loans in the BDC sector. Trinity Capital, and other BDCs, originate loans toAnalyst’s Disclosure: I/we have a beneficial long position in the shares of TRIN, HTGC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha ...